Search Results - "Lukeman, Hannah"

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens by Counoupas, Claudio, Pino, Paco, Stella, Alberto O, Ashley, Caroline, Lukeman, Hannah, Bhattacharyya, Nayan D, Tada, Takuya, Anchisi, Stephanie, Metayer, Charles, Martinis, Jacopo, Aggarwal, Anupriya, Dcosta, Belinda M, Britton, Warwick J, Kint, Joeri, Wurm, Maria J, Landau, Nathaniel R, Steain, Megan, Turville, Stuart G, Wurm, Florian M, David, Sunil A, Triccas, James A

“…Global control of COVID-19 will require the deployment of vaccines capable of inducing long-term protective immunity against SARS-CoV-2 variants. In this…”
Get full text

A unique cytotoxic CD4+ T cell‐signature defines critical COVID‐19 by Baird, Sarah, Ashley, Caroline L, Marsh‐Wakefield, Felix, Alca, Sibel, Ashhurst, Thomas M, Ferguson, Angela L, Lukeman, Hannah, Counoupas, Claudio, Post, Jeffrey J, Konecny, Pamela, Bartlett, Adam, Martinello, Marianne, Bull, Rowena A, Lloyd, Andrew, Grey, Alice, Hutchings, Owen, Palendira, Umaimainthan, Britton, Warwick J, Steain, Megan, Triccas, James A

“…Objectives SARS‐CoV‐2 infection causes a spectrum of clinical disease presentation, ranging from asymptomatic to fatal. While neutralising antibody (NAb)…”
Get full text